TheEdgeResearch
Home / Stocks / IINN

Inspira Technologies OXY B.H.N. Ltd. (IINN)

NASDAQ Healthcare Medical - Devices
$1.05 ▼ -0.94%
Market Cap
$25.3M
Sector
Healthcare
Industry
Medical - Devices
Beta
2.33
52-Wk Range
—
CEO
Dagi Shahar Ben-Noon
Country
IL
Currency
USD

Inspira Technologies OXY B.H.N. Ltd. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Ra'anana, IL. The stock last traded at $1.05, down 0.94% on the session, giving a market capitalisation of $25.3M. On trailing twelve-month figures it carries a trailing P/E of -2.33, a net margin of -4574.4%. Its beta of 2.33 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-2.33
Price / Sales
87.50
Price / Book
13.39
EV / EBITDA
-1.79
Gross margin
-94.1%
Operating margin
-4710.7%
Net margin
-4574.4%
Return on equity
—
Debt / equity
0.67
Current ratio
1.56
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ
Employees
39
IPO date
2021-07-14
Headquarters
Ra'anana, IL
About Inspira Technologies OXY B.H.N. Ltd.

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure in Israel. It offers INSPIRA ART100, a life support system used in procedures requiring cardiopulmonary bypass for six hours or less. It also offers additive manufactured electronics platform that enables 3D architecture for systems operating in dilution cryostats. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'anana, Israel.

Comparable companies

Inspira Technologies OXY B.H.N. Ltd. is most often compared with the following Healthcare names:

BFRIENSCFEEDHSCSISPCPTPIRPIDSSKN
More research on IINN
IINN technical analysis IINN TheEdge Score Compare against peers
Open full interactive analysis & DCF →